Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress

Go back to Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress
(NASDAQ: RCKT) Delayed: 3.39 +0.04 (1.19%)
Previous Close $3.35    52 Week High
Open $3.38    52 Week Low
Day High $3.50    P/E N/A 
Day Low $3.35    EPS
Volume 850,011